Antimetabolites: all 7,305 studies that test it
Page 49 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPICompletedNCT01874522Phase 1
- Long-Term Efficacy and Safety of CT-P10 in Patients With RACompletedNCT01873443Phase 1
- Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01872962Phase 3
- Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)PatientCompletedNCT01871961Phase 1
- Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural MesotheliomaStatus unknownNCT01869023Phase 2
- Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid TumorsCompletedNCT01867879Phase 1
- Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD AloneCompletedNCT01867866Phase 1
- Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid LeukemiaActive, not recruitingNCT01861314Phase 1
- BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment SuccessStatus unknownNCT01860690Phase 4
- A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive BiomarkersStatus unknownNCT01860508Not applicable
- Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsCompletedNCT01858883Phase 1/2
- Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPCStatus unknownNCT01854203Phase 2/3
- Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase ICompletedNCT01852890Phase 1
- Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung CancerCompletedNCT01850303Phase 3
- Neoadjuvant ECS Versus ECF in Local Advanced Breast CancerStatus unknownNCT01849380Phase 4
- A Bioequivalence Study of Capecitabine TabletsCompletedNCT01846650Phase 1
- Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell LymphomaCompletedNCT01846390Phase 1
- Study to Compare Cardiovascular Side Effects of Teysuno Versus CapecitabineCompletedNCT01845337Phase 2
- A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal CancerStatus unknownNCT01843829Phase 2
- Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersCompletedNCT01843725Phase 1
- Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal CanalTerminatedNCT01843452Phase 2
- Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute LeukemiaCompletedNCT01842672Phase 1/2
- High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin LymphomaActive, not recruitingNCT01840566Phase 1
- Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid LeukemiaCompletedNCT01839240Phase 1
- Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive ChemoradiationWithdrawnNCT01836341Phase 1
- A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric CancerStatus unknownNCT01836120Phase 2
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT01834248Phase 1
- Tivozanib + Gemcitabine in Metastatic RCCWithdrawnNCT01834183Phase 2
- EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic CancerCompletedNCT01834170Phase 1
- Study of S-1 in Combination With Radiotherapy in Esophageal CancerCompletedNCT01831531Phase 2
- Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic CancerWithdrawnNCT01830322Phase 2
- Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine TherapyCompletedNCT01828346Phase 1/2
- Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction ChemotherapyCompletedNCT01827553Phase 3
- ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerCompletedNCT01825603Phase 1
- Postoperative Chemoradiotherapy With S-1 in Gastric CancerCompletedNCT01824004Phase 2
- The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)Status unknownNCT01823042Not applicable
- 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAINActive, not recruitingNCT01822652Phase 1
- Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01822015Early Phase 1
- Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerCompletedNCT01821612Early Phase 1
- A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node MetastasisStatus unknownNCT01821248Phase 2
- Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®WithdrawnNCT01820091Phase 1
- Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's DiseaseStatus unknownNCT01817972Phase 3
- Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01815307Phase 2
- Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast CancerCompletedNCT01815242Phase 2
- GFM-Acadesine: A Phase I-II Trial of AcadesineTerminatedNCT01813838Phase 1/2
- Endostar + GT in Pulmonary Metastases of Soft Tissue SarcomaStatus unknownNCT01812018Phase 2
- Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeStatus unknownNCT01809392Phase 2/3
- Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell TransplantationStatus unknownNCT01806116Phase 4
- Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine FailureTerminatedNCT01802593Phase 4
- Neoadjuvant Chemotherapy in Locally Advanced Bladder CancerCompletedNCT01801644Not applicable
- Sickle Cell Disease - Stroke Prevention in Nigeria TrialCompletedNCT01801423Not applicable
- Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid LeukemiaTerminatedNCT01801046Phase 1
- Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell LymphomasStatus unknownNCT01799083Phase 1/2
- AR-42 and Decitabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01798901Phase 1
- XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of StomachStatus unknownNCT01798251Phase 2
- The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung CancerCompletedNCT01797913Phase 2
- Clofarabine for Langerhans in PediWithdrawnNCT01796405Phase 2
- NY-ESO-1 T Cells in OG CancerTerminatedNCT01795976Phase 2
- Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric CancerStatus unknownNCT01795027Phase 3
- Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AMLTerminatedNCT01794169Phase 2
- Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving FolotynWithdrawnNCT01789723Phase 1
- Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative NeoplasmCompletedNCT01787487Phase 2
- Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01787474Phase 1
- Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin LymphomasStatus unknownNCT01786018Phase 2
- Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung CancerCompletedNCT01784640Phase 1
- Elacytarabine Mass Balance Study in Healthy VolunteersCompletedNCT01783964Phase 1
- Gefitinib Versus Pemetrexed for Previously Treated NSCLC PatientsCompletedNCT01783834Phase 2
- Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS MetastasisCompletedNCT01783756Phase 1/2
- Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic CancerCompletedNCT01781520Phase 1/2
- Adjuvant Effect of Chloroquine on GemcitabineCompletedNCT01777477Phase 1
- Allopurinol in Acute GoutWithdrawnNCT01775098Not applicable
- A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous LeukemiaCompletedNCT01773408Phase 1
- A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung CancerCompletedNCT01770795Phase 2
- Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic CancerCompletedNCT01770132Phase 1
- Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWithdrawnNCT01769911Not applicable
- the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia PatientStatus unknownNCT01766375Phase 3
- BAY86-9766 Plus Gemcitabine Phase I Study in AsianCompletedNCT01764828Phase 1
- Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.CompletedNCT01762202Phase 2
- Sorafenib Combined With Chemotherapy for Renal Collecting Duct CarcinomaCompletedNCT01762150Phase 2
- Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II TrialStatus unknownNCT01761461Phase 3
- Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma ProtocolTerminatedNCT01760252Phase 2
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic AnemiaStatus unknownNCT01759732Phase 2
- Chemoradiotherapy for Patients With Oligometastatic Colorectal CancerTerminatedNCT01759238Phase 2
- A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX TherapyStatus unknownNCT01758666Not applicable
- Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell TransplantationStatus unknownNCT01758367Phase 1/2
- Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT01758328Phase 1
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT01754805Phase 1
- Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT01749397Phase 1
- A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction CancerCompletedNCT01748773Phase 2
- CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell LymphomaStatus unknownNCT01746992Phase 4
- Efficacy and Safety Study of Tacrobell to Treat Rheumatoid ArthritisCompletedNCT01746680Phase 4
- Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLCStatus unknownNCT01742767Phase 2
- The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)Status unknownNCT01741558Phase 2
- Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal CancerCompletedNCT01740648Phase 1
- Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by SurgeryTerminatedNCT01739439Phase 1
- Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot StudyCompletedNCT01737671Early Phase 1
- A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerCompletedNCT01736410Phase 2
- Adjuvant Post-radical Cystectomy Treatment for Bladder CancerCompletedNCT01734798Phase 3
- A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal CancerStatus unknownNCT01732380Phase 2